Inhibition of ligand-independent cap formation of mouse lymphocytes and Raji cells by neocarzinostatin.
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D002051:Burkitt Lymphoma / Q000188:drug therapy* / Q000276:immunology; D002460:Cell Line; D002462:Cell Membrane / Q000187:drug effects; D003208:Concanavalin A / Q000494:pharmacology; D003599:Cytoskeleton / Q000187:drug effects; D005347:Fibroblasts / Q000187:drug effects; D006801:Humans; D007152:Immunologic Capping / Q000187:drug effects*; D008214:Lymphocytes / Q000187:drug effects* / Q000276:immunology; D051379:Mice; D008870:Microtubules / Q000187:drug effects; D009353:Zinostatin / Q000494:pharmacology*
D000903:Antibiotics, Antineoplastic; D003208:Concanavalin A; D009353:Zinostatin